Unleashing Industry Insights, Connecting the Future
Poly (ADP-ribose) polymerase (PARP) inhibitors are medications used for treating cancer such as breast cancer, ovarian cancer and prostate cancer. They work by blocking an …
The PARP inhibitor market consists of pharmaceutical drugs belonging to the class of PARP inhibitors. These drugs are used for the treatment of various types …
Market Overview The global PARP Inhibitor Market is estimated to be valued at US$887.7 million in 2018 and is projected to reach US$ (incorporate given …
by